SAHPRA-2022-0098-V298

Major variation for application SAHPRA-2022-0098. Major variation: Specification Change for Crizotinabex — critical change

Variation Number
SAHPRA-2022-0098-V298
Type
Major
Application
SAHPRA-2022-0098
Change
CHG-2023-0298
Status
Approved
Fee
€28,903
Submitted
2023-03-21
Approved
2023-11-30
Description

Major variation: Specification Change for Crizotinabex — critical change